Keywords
Last Name
Institution

Sarah W. Book

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
458N
67 President St.
Phone843-792-5200
Fax843-792-7353
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr Book's general interests are related to helping people with drug and alcohol problems that co-occur with depression and anxiety. As the Medical Director of our addictions treatment program, she is a member of an inter-professional team of Psychologists and Social Workers who all work together to help patients reach their goals. She also mentors medical students, psychiatry residents, and addiction psychiatry fellows, supervising them in their clinical work. Her research interests include finding effective medication interventions, as well as developing educational programs to teach trainees about helping people with drug and alcohol problems, and encouraging MD trainees to pursue careers that include research.

    Collapse keywords
    Alcohol dependence, anxiety, addiction treatment, developing educational programs

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Anton RF, Latham PK, Voronin KE, Randall PK, Book SW, Hoffman M, Schacht JP. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res. 2018 Apr; 42(4):751-760. PMID: 29431852.
      View in: PubMed
    2. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 12; 42(13):2654. PMID: 29123234.
      View in: PubMed
    3. Campbell ANC, Back SE, Ostroff JS, Hien DA, Gourevitch MN, Sheffer CE, Brady KT, Hanley K, Bereket S, Book S. Addiction Research Training Programs: Four Case Studies and Recommendations for Evaluation. J Addict Med. 2017 Sep/Oct; 11(5):333-338. PMID: 28590393.
      View in: PubMed
    4. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 Dec; 42(13):2640-2653. PMID: 28409564.
      View in: PubMed
    5. Bentzley BS, Barth KS, Back SE, Aronson G, Book SW. Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. J Subst Abuse Treat. 2015 Sep; 56:48-53. PMID: 25899872.
      View in: PubMed
    6. Bentzley BS, Barth KS, Back SE, Book SW. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abuse Treat. 2015 May; 52:48-57. PMID: 25601365.
      View in: PubMed
    7. Miller PM, Book SW, Thomas S, Smith JP, Randall PK, Randall CL. The potential utility of drinking motive questions to screen at-risk drinking in socially anxious patients. J Subst Use. 2014 Jun 01; 19(3):225-228. PMID: 24982593.
      View in: PubMed
    8. Cluver J, Book S, Brady K, Back S, Thornley N. Engaging medical students in research: reaching out to the next generation of physician-scientists. Acad Psychiatry. 2014 Jun; 38(3):345-9. PMID: 24913099.
      View in: PubMed
    9. Anton RF, Schacht JP, Book SW. Pharmacologic treatment of alcoholism. Handb Clin Neurol. 2014; 125:527-42. PMID: 25307594.
      View in: PubMed
    10. Book SW, Thomas SE, Smith JP, Randall PK, Kushner MG, Bernstein GA, Specker SM, Miller PM, Randall CL. Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine. J Anxiety Disord. 2013 Mar; 27(2):252-8. PMID: 23523988.
      View in: PubMed
    11. Book SW, Thomas SE, Smith JP, Miller PM. Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbid. Addict Behav. 2012 Oct; 37(10):1158-61. PMID: 22658305.
      View in: PubMed
    12. Book SW, Thomas SE, Stewart SH, Miller PM. Client attitudes toward alcohol use self-report. Subst Abus. 2012; 33(2):124-9. PMID: 22489584.
      View in: PubMed
    13. Back SE, Book SW, Santos AB, Brady KT. Training physician-scientists: a model for integrating research into psychiatric residency. Acad Psychiatry. 2011 Jan-Feb; 35(1):40-5. PMID: 21209406.
      View in: PubMed
    14. Miller PM, Book SW, Stewart SH. Medical treatment of alcohol dependence: a systematic review. Int J Psychiatry Med. 2011; 42(3):227-66. PMID: 22439295.
      View in: PubMed
    15. Tonigan JS, Book SW, Pagano ME, Randall PK, Smith JP, Randall CL. 12-Step Therapy and Women with and without Social Phobia: A Study of the Effectiveness of 12-Step Therapy to Facilitate AA Engagement. Alcohol Treat Q. 2010 Apr 01; 28(2):151-162. PMID: 21423569.
      View in: PubMed
    16. Madan A, Borckardt JJ, Connell A, Book SB, Campbell S, Gwynette MF, Wimberly LA, Wagner M, Weinstein B, McLeod-Bryant S, Cooney H, Herbert J. Routine assessment of patient-reported outcomes in behavioral health: room for improvement. Qual Manag Health Care. 2010 Jan-Mar; 19(1):70-81. PMID: 20042935.
      View in: PubMed
    17. Smith JP, Book SW. Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment. Addict Behav. 2010 Jan; 35(1):42-5. PMID: 19733441.
      View in: PubMed
    18. Book SW, Thomas SE, Dempsey JP, Randall PK, Randall CL. Social anxiety impacts willingness to participate in addiction treatment. Addict Behav. 2009 May; 34(5):474-6. PMID: 19195794.
      View in: PubMed
    19. Smith JP, Book SW. Anxiety and Substance Use Disorders: A Review. Psychiatr Times. 2008 Oct; 25(10):19-23. PMID: 20640182.
      View in: PubMed
    20. Dempsey JP, Randall PK, Thomas SE, Book SW, Carrigan MH. Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms. Compr Psychiatry. 2009 Mar-Apr; 50(2):135-41. PMID: 19216890.
      View in: PubMed
    21. Thomas SE, Miller PM, Randall PK, Book SW. Improving acceptance of naltrexone in community addiction treatment centers: a pilot study. J Subst Abuse Treat. 2008 Oct; 35(3):260-8. PMID: 18329227.
      View in: PubMed
    22. Thomas SE, Randall PK, Book SW, Randall CL. A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res. 2008 Jan; 32(1):77-84. PMID: 18028529.
      View in: PubMed
    23. Book SW, Myrick H, Malcolm R, Strain EC. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry. 2007 Jun; 164(6):979. PMID: 17541066.
      View in: PubMed
    24. Book SW, Thomas SE, Randall PK, Randall CL. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. J Anxiety Disord. 2008; 22(2):310-8. PMID: 17448631.
      View in: PubMed
    25. Book SW, Myrick H. Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs. 2005 Apr; 14(4):371-6. PMID: 15882114.
      View in: PubMed
    26. Malcolm R, Book SW, Moak D, DeVane L, Czepowicz V. Clinical applications of modafinil in stimulant abusers: low abuse potential. Am J Addict. 2002; 11(3):247-9. PMID: 12202017.
      View in: PubMed
    27. Emmanuel NP, Brawman-Mintzer O, Morton WA, Book SW, Johnson MR, Lorberbaum JP, Ballenger JC, Lydiard RB. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3. PMID: 11091936.
      View in: PubMed
    28. Lorberbaum JP, Newman JD, Dubno JR, Horwitz AR, Nahas Z, Teneback CC, Bloomer CW, Bohning DE, Vincent D, Johnson MR, Emmanuel N, Brawman-Mintzer O, Book SW, Lydiard RB, Ballenger JC, George MS. Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety. 1999; 10(3):99-104. PMID: 10604082.
      View in: PubMed
    29. Connor KM, Davidson JR, Potts NL, Tupler LA, Miner CM, Malik ML, Book SW, Colket JT, Ferrell F. Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol. 1998 Oct; 18(5):373-8. PMID: 9790154.
      View in: PubMed
    30. Davidson JR, Book SW, Colket JT, Tupler LA, Roth S, David D, Hertzberg M, Mellman T, Beckham JC, Smith RD, Davison RM, Katz R, Feldman ME. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med. 1997 Jan; 27(1):153-60. PMID: 9122295.
      View in: PubMed
    31. Potts NL, Book S, Davidson JR. The neurobiology of social phobia. Int Clin Psychopharmacol. 1996 Jun; 11 Suppl 3:43-8. PMID: 8923109.
      View in: PubMed
    32. Muly EC, McDonald W, Steffens D, Book S. Serotonin syndrome produced by a combination of fluoxetine and lithium. Am J Psychiatry. 1993 Oct; 150(10):1565. PMID: 8379573.
      View in: PubMed
    Book's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _